In the Media: Michael J. Fox Foundation Supports McLean Research Project
Biospace.com
McLean’s Neuroregeneration Research Institute awarded $625,000 to fund development of a cutting-edge therapy to replace the dopamine neurons that degenerate in Parkinson’s disease.
Media Requests
Journalist or member of the media?
We are available 24/7 for media requests.
